Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Universitätsmedizin Mannheim
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Device Adherence/Compliance
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
Cancer is becoming a chronic disease, with the requirement of a lifelong intake of cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer patients may require a more customized and tailored follow up.
Most elderly patients have multiple other diseases ("comorbidities") and, due to many other factors, may per se not tolerate or simply not follow anticancer therapies. This may not only impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival).
Handheld devices provide a new reporting/communication tool for patients and health care providers. TeleGraPH will assess if these devices are a suitable communication modality in a cohort of geriatric cancer patients.
Investigators
Frederik Wenz
Director and Chief Medical Officer
Universitätsmedizin Mannheim
Eligibility Criteria
Inclusion Criteria
- •Age \> 60 years
- •Karnofsky Performance Status ≥ 70
- •histologically confirmed malignant tumor (cancer)
Exclusion Criteria
- •concurrent severe and/or uncontrolled concomitant medical conditions
- •Patients unwilling or unable to comply with using a handheld device
Outcomes
Primary Outcomes
Device Adherence/Compliance
Time Frame: 1 Year
Frequency of using the handheld device and of daily/weekly/monthly reportings
Secondary Outcomes
- Quality of Life(1 Year)
- Reliability of reports(1 Year)